| Literature DB >> 31941048 |
Ioannis Ketikidis1, Christina N Banti1, Nikolaos Kourkoumelis2, Constantinos G Tsiafoulis3, Christina Papachristodoulou4, Angelos G Kalampounias5, Sotiris K Hadjikakou1,6.
Abstract
Conjugation of penicillin G (PenH) with silver(I) ions forms a new CoMeD (conjugate of metal with a drug) with formula [Ag(pen)(CH3OH)]2 (PenAg). PenAg was characterized by a plethora of physical and spectroscopic techniques, which include in the solid state m.p.; elemental analysis; X-ray fluorescence (XRF) spectroscopy; scanning electron microscopy (SEM); energy-dispersive X-ray spectroscopy (EDX); FT-IR; and in solution: attenuated total reflection spectroscopy (FT-IR-ATR), UV-Vis, 1H NMR, and atomic absorption (AA). The structure of PenAg was determined by NMR spectroscopy. Silver(I) ions coordinate to the carboxylic group of PenH, while secondary intra-molecular interactions are developed through (i) the nitrogen atom of the amide group in MeOD-d4 or (ii) the sulfur atom in the thietane ring in deuterated dimethyl sulfoxide DMSO-d6. The antibacterial activities of PenAg and the sodium salt of penicillin (PenNa) (the formulation which is clinically used) against Gram positive (Staphylococcus epidermidis (S. epidermidis) and Staphylococcus aureus (S. aureus)) and Gram negative (Pseudomonas aeruginosa (P. aeuroginosa PAO1)) bacteria were evaluated by the means of minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and inhibition zone (IZ). PenAg inhibits the growth of the Gram negative bacterial strain P. aeuroginosa with a MIC value of 23.00 ± 2.29 μM, in contrast to PenNa, which shows no such activity (>2 mM). The corresponding antimicrobial activities of PenAg against the Gram positive bacteria S. epidermidis and S. aureus are even better than those of PenNa. Moreover, PenAg exhibits no in vivo toxicity against Artemia salina at concentration up to 300 μΜ. The wide therapeutic window and the low toxicity, make PenAg a possible candidate for the development of a new antibiotic.Entities:
Keywords: Diffusion-Ordered NMR Spectroscopy (DOSY-NMR); antimicrobial activity; biological inorganic chemistry; modified antibiotic; penicillin; toxicity
Year: 2020 PMID: 31941048 PMCID: PMC7168214 DOI: 10.3390/antibiotics9010025
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Scheme 1Molecular structure of Penicillin G.
Scheme 2PenAg synthetic route.
Figure 1SEM image accompanied by EDX qualitative analysis. The dot marks the location of EDX (A). EDX chemical maps (B–C).
Figure 21H-NMR spectrum in DMSO-d of PenAg and the corresponding ones after 0, 24 and 48 h.
Figure 3ATR-FTIR spectra of solutions with DMSO and CHCl3 as solvents and of the solid phase. The spectra exhibit characteristic similarities in both liquid and solid phases.
Pearson correlation coefficients for solid and solution with CHCl3 or DMSO used as solvents.
| Solid/KBr | CHCl3 | Solid/KBr | DMSO | |||
|---|---|---|---|---|---|---|
|
| 1 | 0.78715 |
| 1 | 0.80955 | |
|
| 0.78715 | 1 |
| 0.80955 | 1 |
Figure 4Confidence ellipses calculated from Pearson-type correlations for the solid and the solution with CHCl3 (A) or DMSO (B) used as solvent. See text for details.
Figure 5Synchronous 2-D correlation spectra constructed from the vibrational spectra of the solid and CHCl3 (A) or DMSO (B) solution presented in Figure 3.
Figure 6The Δδ for the PenNa and the PenAg in DMSO-d6 (a) and in MeOD-d4 (b).
Figure 7Structure of PenAg refined by the analytical and spectroscopic data.
Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and inhibition zones (IZ) of PenAg and PenNa in comparison with the corresponding ones of other silver and zinc complexes tested against P. aeruginosa, S. epidermidis, and S. aureus.
| Compound | MIC values (μΜ) | Ref. | ||
|---|---|---|---|---|
|
|
|
| ||
|
| 23.00 ± 2.29 | 2.41 ± 0.88 | 0.08 ± 0.02 | [*] |
|
| >2000 | 3.76 ± 1.14 | 0.14 ± 0.02 | [*] |
| CIPAG | 0.61 ± 0.14 | 0.46 ± 0.08 | 0.54 ± 0.07 | [ |
| ([CIPH2+]·Cl−) | 1.17 ± 0.22 | 1.08 ± 0.12 | 1.45 ± 0.12 | [ |
| AGSAL-1 | 28 | 50 | 42 | [ |
| salH2 | >1250 | >1250 | >1250 | [ |
| AGMNA | 25.7 ± 2.4 | - | 42.0 ± 0.3 | [ |
| MNAH2 | >300 | - | >300 | [ |
| [Zn3(CitH)2] | >250 | 119.2 ± 18.1 | 183.3 ± 31.4 | [ |
| CitH4 | >250 | >250 | >250 | [ |
| MBC values (μΜ) | ||||
|
| 46.6 | - | - | [*] |
|
| 2000 | - | - | [*] |
| CIPAG | 0.7 | 0.8 | 1.0 | [ |
| ([CIPH2+]·Cl−) | 1.60 | 1.60 | 2.00 | [ |
| AGSAL-1 | 33.0 | 90.0 | 50.0 | [ |
| salH2 | ND | ND | ND | [ |
| AGMNA | 61.1 | - | 85.7 | [ |
| MNAH2 | 153.3 | - | 135.0 | [ |
| [Zn3(CitH)2] | >250 | 201.7 | >250 | [ |
| CitH4 | >250 | >250 | >250 | [ |
| Inhibition zone (mm) | ||||
|
| 10 | 10 | 10 | |
|
| 17 | 34 | 57 | [*] |
|
| 10 | 34 | 60 | [*] |
| CIPAG | 32 | 34 | 28 | [ |
| ([CIPH2+]·Cl−) | 30 | 36 | 24 | [ |
| AGSAL-1 | 13 | 13 | 12 | [ |
| salH2 | 10 | 10 | 10 | [ |
| AGMNA | 21.8 | - | 22.1 | [ |
| MNAH2 | 10 | 10 | 10 | [ |
| [Zn3(CitH)2] | 10 | 10 | 10 | [ |
| CitH4 | 10 | 10 | 10 | [ |
[*] this work, ND = not determined, CIPAG= {[Ag(CIPH)2]NO3∙0.75MeOH∙1.2H2O}, CIPH = ciprofloxacin, [CIPH2+]·Cl− = hydrochloric salt of ciprofloxacin, AGSAL-1 = [Ag(salH)]2, salH2 = salicylic acid, AGMNA = {[Ag6(μ3-Hmna)4(μ3-mna)2]2−·[(Et3NH)+]2·(DMSO)2·(H2O)}, MNAH2 = 2-mercapto-nicotinic acid, CitH4 = citric acid.
Figure 8Inhibition zones which are grown in Pseudomonas aeruginosa (A), Staphylococcus epidermidis (B), and Staphylococcus aureus (C) for PenAg and PenNa.